{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:36:30Z","timestamp":1778214990396,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,10,30]],"date-time":"2002-10-30T00:00:00Z","timestamp":1035936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cerebrovascular accident (CVA) is a major cause of morbidity and death in sickle cell anemia (SCA). Transfusion of packed erythrocytes is widely used to prevent this complication. However, chronic transfusion may lead to iron overload, alloimmunization, or infections. Cost and compliance may compromise transfusion therapy. A possible alternative, the prophylactic use of hydroxyurea (HU), has not been tried to determine whether it may prevent recurrent stroke. We used HU in five children with SCA who had suffered stroke, in three of them after a first episode and in the other two after a second CVA. Four had infarctive stroke and one a transient ischemic attack (TIA). Four patients took HU at a dose of 40 mg\/kg\/d, one patient at 30 mg\/kg\/d. None of the patients had recurrent stroke during 42\u2013112 months of observation. None experienced pain crises. In all, HbF increased significantly and was maintained above 14.7% during treatment. The total Hb concentration increased 19.5 g\/L (median) above the value before treatment. HU was well tolerated. None of the five children had leukopenia or thrombocytopenia during therapy. HU appears to prevent recurrence of stroke in SCA without risk of major toxicity. Am. J. Hematol. 71:161\u2013165, 2002. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.10205","type":"journal-article","created":{"date-parts":[[2002,10,31]],"date-time":"2002-10-31T18:20:30Z","timestamp":1036088430000},"page":"161-165","source":"Crossref","is-referenced-by-count":55,"title":["Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)"],"prefix":"10.1002","volume":"71","author":[{"given":"Abraham","family":"Sumoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"de Bisotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sumoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgil","family":"Fairbanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,10,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"418a","article-title":"Fetal hemoglobin (Hb F) in sickle cell anemia (Hb SS): determinants of response to hydroxyurea (HU)","volume":"86","author":"Steinberg MH","year":"1995","journal-title":"Blood"},{"issue":"1","key":"e_1_2_1_3_2","first-page":"67a","article-title":"Treatment of sickle cell anemia with hydroxyurea: results in 26 patients","volume":"68","author":"Sumoza A","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331514"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510123331514"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1542\/peds.84.3.500","article-title":"Mortality in children and adolescents with sickle cell disease","volume":"84","author":"Leikin SL","year":"1989","journal-title":"Pediatrics"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_1_9_2","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene\u2010Frempong K","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90772-6"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.7.1431.1431"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/1841877a0"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390102"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.1.162.162"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(95)70204-0"},{"key":"e_1_2_1_16_2","volume-title":"Sickle cell disease: basic principles and clinical practice","author":"Embury SH","year":"1994"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111464"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221504"},{"issue":"1","key":"e_1_2_1_19_2","first-page":"35b","article-title":"Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA)","volume":"92","author":"Sumoza A","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V94.9.3022","article-title":"Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease","volume":"94","author":"Ware RE","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371107"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199611000-00002"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood.V83.2.553.553","article-title":"Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells","volume":"83","author":"Adragna NC","year":"1994","journal-title":"Blood"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood.V88.12.4701.bloodjournal88124701","article-title":"A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy","volume":"88","author":"Bridges KR","year":"1996","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.23.8.1073"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70335-9"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V93.6.1787.406a34_1787_1789","article-title":"Induction of fetal hemoglobin in sickle cell disease","volume":"93","author":"Bunn HF","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_28_2","first-page":"1550","article-title":"Safety of hydroxyurea in children with sickle cell anemia: results of the HUG\u2010KIDS study, a Phase I\/II Trial","volume":"94","author":"Kinney TR","year":"1999","journal-title":"Blood"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3628"},{"key":"e_1_2_1_30_2","first-page":"PO","article-title":"The effect of hydroxyurea in sickle cell disease: a European registry of benefits and toxicity (Abstract)","volume":"84","author":"Davies SC","year":"1999","journal-title":"Haematology"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.10205","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.10205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T14:18:49Z","timestamp":1700317129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.10205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,30]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1002\/ajh.10205"],"URL":"https:\/\/doi.org\/10.1002\/ajh.10205","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,30]]}}}